Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQRT.L Regulatory News (QRT)

  • There is currently no data for QRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

17 Oct 2017 16:31

RNS Number : 8636T
Quarto Group Inc
17 October 2017
 

The Quarto Group, Inc.

 

("Quarto", "the Group" or "the Company") 

 

NOTIFICATION OF TRANSACTION OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY ("PDMR") OR PERSONS CLOSELY ASSOCIATED WITH THEM ("PCA")

 

 

In accordance with Disclosure Rule 3.1.4R(1), Quarto announces that it has received notice of the following acquisition:

Claire Capeci, Non-Executive Director, acquired 2,500 shares of common stock of US$0.10 each ("Shares") in Quarto at a price of USD1.8347 per Share on 13 October 2017.

Following this transaction, Claire Capeci holds 2,500, Shares representing 0.012% of Quarto's issued share capital.

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

 

 

1

Details of person discharging managerial responsibilities/person closely associated

a)

Name

Claire Capeci

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

INITIAL NOTIFICATION

3

Details of the issuer, emissions, allowance market participant, auction platorm, auctioneer or auction monitor

a)

Name

THE QUARTO GROUP, INC.

b)

LEI

549300BJ2WPX3QUATW58

4)

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

SHARES OF COMMON STOCK OF US$0.10 EACH ("SHARES")

 

Identification Code

US74772E1001

b)

Nature of the transaction

ACQUISITION OF SHARES

c)

Price(s) and volume(s)

Price(s)

Volumes(s)

 

 

USD1.8347

2,500

d)

Aggregated information

 

 

- aggregated volume

 

 

- price

 

e)

Date of transaction

13 October 2017

f)

Place of transaction

LONDON STOCK EXCHANGE (XLON)

(1) Commission Delegated Regulation (EU) 2016/522 of 17 December 2015 supplementing Regulation (EU) No. 596/2014 of the European Parliament and of the Council as retards an exemption for certain third countries public bodies and central banks, the indicators of market manipulation, the disclosure thresholds, the competent authority for notification of delays, the permission for trading during closed periods and types of notifiable managers' transactions (see page 1 of this Official Journal).

 

 

Ends

 

 

  

For further information, please contact:

 

The Quarto Group

Marcus Leaver, CEO

+44 (0)20 7700 9002

Dorothee de Montgolfier, Group Director of Communications

 

About The Quarto Group

 

The Quarto Group (LSE: QRT) is the leading global illustrated book publishing group. Our mission is to make and sell great books that entertain, educate and enrich the lives of adults and children around the world.

 

Quarto creates and owns proprietary content, publishing books from a diverse portfolio of imprints that are creatively independent and expert in developing long-lasting content across specific niches of interest.

 

Quarto sells books across 50 countries and in 39 languages through a variety of traditional and non-traditional channels, while constantly looking for new ways to create and deliver content that people need.

 

Quarto employs over 400 talented people in the US, UK and Hong Kong. The group was founded in London in 1976. It is domiciled in the US and listed on the London Stock Exchange. 

 

For more information, visit quarto.com or follow us on Twitter at @TheQuartoGroup.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKODBPBDDCKD
Date   Source Headline
8th Sep 20205:02 pmRNSDirector/PDMR Shareholding
28th Jul 20203:45 pmRNSHalf-year Report
24th Jun 20203:16 pmRNSResult of Annual Meeting
28th May 20209:50 amRNSAnnual Financial Report
23rd Apr 20207:00 amRNSFinal Results
25th Mar 20209:57 amRNSTrading Statement
25th Mar 20207:00 amRNSTrading Statement
26th Feb 20201:10 pmRNSHolding(s) in Company
10th Feb 20202:29 pmRNSDirectorate Change
6th Feb 20209:13 amRNSHolding(s) in Company
4th Feb 20207:00 amRNSDirector/PDMR Shareholding
3rd Feb 20207:00 amRNSResult of Open Offer
31st Jan 202010:35 amRNSResult of Special Meeting
28th Jan 20205:42 pmRNSStatement re: Media Speculation
16th Jan 20203:45 pmRNSPublication of Prospectus and Circular
16th Jan 20207:00 amRNSOpen Offer to raise £13.9 million
15th Jan 20206:26 pmRNSIntention to launch an Open Offer
8th Nov 20194:32 pmRNSChange of Adviser
16th Aug 20197:00 amRNSHalf-Year Results
11th Jul 20198:17 amRNSChange of Broker
1st Jul 20191:30 pmRNSAppointment of CFO
14th Jun 20195:29 pmRNSHolding(s) in Company
11th Jun 20193:42 pmRNSHolding(s) in Company
11th Jun 201911:00 amRNSHolding(s) in Company
10th Jun 20195:32 pmRNSDirector/PDMR Shareholding
16th May 20195:12 pmRNSAnnual Meeting Result
25th Apr 20194:59 pmRNSAppointment of Non-Executive Director & CFO
23rd Apr 20194:59 pmRNSAnnual Financial Report
14th Mar 20193:33 pmRNSDirector Declaration
11th Mar 20197:00 amRNSFinal Results for the Year Ended 31 December 2018
27th Feb 20192:56 pmRNSDirector Declaration
6th Dec 20181:27 pmRNSDirector/PDMR Shareholding
14th Nov 20184:01 pmRNSDirector/PDMR Shareholding
12th Nov 20187:00 amRNSDirector Declaration
1st Nov 20187:00 amRNSExtension and amendment of banking facilities
15th Oct 20183:05 pmRNSDirector Declaration
17th Sep 20187:00 amRNSHalf-year Report
15th Aug 201811:30 amRNSSpecial Meeting result
30th Jul 20188:00 amRNSNotice of Special Meeting of Shareholders
26th Jul 201811:06 amRNSBoard change
17th Jul 20183:25 pmRNSBoard appointment disclosure
12th Jul 201812:05 pmRNSBoard changes
5th Jun 201811:09 amRNSCFO Resignation & Board Change
24th May 20183:10 pmRNSCEO resignation
22nd May 201811:55 amRNSListing Rule 9.6.13R Disclosure
17th May 20185:49 pmRNSUpdate on roles of new Directors
17th May 20185:45 pmRNSChange of Control
17th May 201812:24 pmRNSAnnual Meeting statement and result
2nd May 20185:45 pmRNSHolding(s) in Company
23rd Apr 20187:00 amRNSAnnual Report and Notice of Annual Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.